{{$root.universalMessage.text}}

US Congress HR1730

To amend the Federal Food, Drug, and Cosmetic Act to accelerate development of therapies across the spectrum of rare diseases and conditions and facilitate patient access to such therapies, and for other purposes.

Table of Contents